Kit Simpson to Models, Econometric
This is a "connection" page, showing publications Kit Simpson has written about Models, Econometric.
Connection Strength
0.259
-
Cost-effectiveness analysis of lopinavir/ritonavir and atazanavir+ritonavir regimens in the CASTLE study. Adv Ther. 2009 Feb; 26(2):185-93.
Score: 0.081
-
Comparison of Markov model and discrete-event simulation techniques for HIV. Pharmacoeconomics. 2009; 27(2):159-65.
Score: 0.080
-
Modeling the use of triple combination therapy in five countries: nevirapine, Zidovudine, and Didanosine. Value Health. 2000 May-Jun; 3(3):186-201.
Score: 0.044
-
The cost-effectiveness of treatment with lamivudine and zidovudine compared with zidovudine alone: a comparison of Markov model and trial data estimates. Am J Manag Care. 1998 Jul; 4(7):1004-12.
Score: 0.039
-
Potential cost savings of decreased emergency department visits through increased continuity in a pediatric medical home. Ambul Pediatr. 2004 May-Jun; 4(3):204-8.
Score: 0.015